Allspring Global Investments
VNDA icon

Allspring Global Investments’s Vanda Pharmaceuticals VNDA Stock Holding History

Allspring Global Investments’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-69,021
Closed -$317K – 1807
2025
Q1 		$317K Sell
69,021
-4,837
-7% -$22.5K ﹤0.01% 1571
2024
Q4 		$354K Sell
73,858
-77,738
-51% -$373K ﹤0.01% 1544
2024
Q3 		$711K Buy
151,596
+168
+0.1% +$901 ﹤0.01% 1400
2024
Q2 		$856K Sell
151,428
-9,043
-6% -$46.7K ﹤0.01% 1370
2024
Q1 		$660K Sell
160,471
-90,666
-36% -$363K ﹤0.01% 1463
2023
Q4 		$1.06M Sell
251,137
-62,482
-20% -$252K ﹤0.01% 1328
2023
Q3 		$1.35M Buy
313,619
+113,139
+56% +$629K ﹤0.01% 1291
2023
Q2 		$1.32M Sell
200,480
-596,912
-75% -$3.83M ﹤0.01% 1344
2023
Q1 		$5.41M Buy
797,392
+565,510
+244% +$3.98M 0.01% 971
2022
Q4 		$1.71M Buy
231,882
+39,918
+21% +$389K ﹤0.01% 1290
2022
Q3 		$1.9M Buy
191,964
+189,173
+6,778% +$2M ﹤0.01% 1245
2022
Q2 		$30K Sell
2,791
-81,005
-97% -$839K ﹤0.01% 2397
2022
Q1 		$947K Sell
83,796
-17,181
-17% -$226K ﹤0.01% 1908
2021
Q4 		$1.58M Buy
+100,977
New +$1.76M ﹤0.01% 1669

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Allspring Global Investments's VNDA Position: Q2 2025 in Review

Allspring Global Investments sold out of Vanda Pharmaceuticals (VNDA) in Q2 2025, closing a stake of 69,021 shares — an estimated $317K sold.

Allspring Global Investments first reported a position in VNDA in Q4 2021 and held it in 14 quarters. The position peaked at $5.41M in Q1 2023. 139 funds tracked by Wall St. Rank hold VNDA as of Q2 2025.

  • Allspring Global Investments reported no remaining Vanda Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Allspring Global Investments sold 69,021 Vanda Pharmaceuticals shares in Q2 2025, an estimated $317K.
  • Allspring Global Investments first reported a position in Vanda Pharmaceuticals in Q4 2021 and held it in 14 quarters.
  • Allspring Global Investments's Vanda Pharmaceuticals position peaked at $5.41M in Q1 2023.
  • 139 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2025.

Based on Allspring Global Investments's 13F filing for Q2 2025, filed 25 Jul 2025.